Pharmacovigilance for psychiatrists: An introduction.
作者信息
Rajkumar Ravi Philip, Melvin George
机构信息
Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.
Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.
出版信息
Indian J Psychiatry. 2014 Apr;56(2):176-81. doi: 10.4103/0019-5545.130502.
Abstract
摘要
相似文献
1
Pharmacovigilance for psychiatrists: An introduction.精神科医生的药物警戒：介绍
Indian J Psychiatry. 2014 Apr;56(2):176-81. doi: 10.4103/0019-5545.130502.
2
Pharmacovigilance of psychoactive medications in a Mexican psychiatric hospital.墨西哥一家精神病医院中精神活性药物的药物警戒
Proc West Pharmacol Soc. 2010;53:44-5.
3
[Introduction of pharmacovigilance in a new university hospital in Morocco: how and why].[摩洛哥一家新建大学医院的药物警戒介绍：方式与原因]
East Mediterr Health J. 2012 Jun;18(6):648-52.
4
Psychiatrists' and dentists' knowledge and attitudes regarding adverse drug reactions of psychotropic drugs.精神科医生和牙医对精神药物不良反应的知识和态度。
Psychiatry Res. 2018 Aug;266:323-327. doi: 10.1016/j.psychres.2018.03.031. Epub 2018 Mar 17.
5
[Translation and introduction of Guide to Methodological Standards in Pharmacoepidemiology].《药物流行病学方法学标准指南》的翻译与介绍
Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):2949-57.
6
Causality in Pharmacoepidemiology and Pharmacovigilance: a theoretical excursion.药物流行病学与药物警戒中的因果关系：一次理论探讨
Rev Bras Epidemiol. 2017 Jul-Sep;20(3):475-486. doi: 10.1590/1980-5497201700030010.
7
Pharmacovigilance in perspective.药物警戒的视角
Drug Saf. 1999 Dec;21(6):429-47. doi: 10.2165/00002018-199921060-00001.
8
[Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal].[生物制品和生物类似药：葡萄牙药物警戒系统中的差距]
Acta Med Port. 2017 Mar 31;30(3):205-212. doi: 10.20344/amp.8079.
9
[The importance of intra-hospital pharmacovigilance in the detection of medication errors].[医院内药物警戒在药物差错检测中的重要性]
Gac Med Mex. 2018;154(2):172-179. doi: 10.24875/GMM.18002549.
10
Pharmacovigilance in developing countries (part II): a path forward.发展中国家的药物警戒（第二部分）：前进之路。
Int J Clin Pharm. 2018 Aug;40(4):764-768. doi: 10.1007/s11096-017-0588-2.
引用本文的文献
1
Mental health services implementation in Colombia-A systematic review.哥伦比亚心理健康服务的实施——一项系统综述
PLOS Glob Public Health. 2023 Dec 6;3(12):e0001565. doi: 10.1371/journal.pgph.0001565. eCollection 2023.
2
Adverse Drug Reactions Associated With Drugs Prescribed in Psychiatry: A Retrospective Descriptive Analysis in a Tertiary Care Hospital.与精神科处方药物相关的药物不良反应：三级护理医院的回顾性描述性分析
Cureus. 2021 Nov 12;13(11):e19493. doi: 10.7759/cureus.19493. eCollection 2021 Nov.
3
Quantifying and Categorizing ADRs in Psychiatric Residential Long-Stay Patients Utilizing UKU-SERS Scale.利用UKU-SERS量表对精神科长期住院患者的药物不良反应进行量化和分类
Indian J Psychol Med. 2021 Jan;43(1):38-44. doi: 10.1177/0253717620926784. Epub 2020 Aug 20.
4
Assessment of incidence, causality, severity, and preventability of suspected adverse drug reactions to antidepressant medications in a psychiatry outpatient setting of a secondary care hospital.在一家二级护理医院的精神科门诊环境中，评估对抗抑郁药物疑似药物不良反应的发生率、因果关系、严重程度及可预防性。
J Pharm Bioallied Sci. 2020 Apr-Jun;12(2):131-138. doi: 10.4103/jpbs.JPBS_196_19. Epub 2020 Apr 10.
5
A systematic approach for developing a corpus of patient reported adverse drug events: A case study for SSRI and SNRI medications.构建患者报告的药物不良事件语料库的系统方法：以SSRI和SNRI药物为例的案例研究。
J Biomed Inform. 2019 Feb;90:103091. doi: 10.1016/j.jbi.2018.12.005. Epub 2019 Jan 4.
6
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country.发展中国家精神药物药物警戒的前瞻性监测
Psychopharmacol Bull. 2016 Mar 1;46(1):54-66.
7
Current challenges in practice of psychiatry in India.印度精神病学实践中的当前挑战。
Indian J Psychiatry. 2015 Apr-Jun;57(2):125-30. doi: 10.4103/0019-5545.158132.
本文引用的文献
1
Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression.迟发性烦躁：长期使用抗抑郁药引发慢性抑郁症的作用。
Med Hypotheses. 2011 Jun;76(6):769-73. doi: 10.1016/j.mehy.2011.01.020. Epub 2011 Apr 2.
2
Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital.印度教学医院精神科门诊的药物不良反应监测。
Indian J Pharmacol. 2011 Feb;43(1):36-9. doi: 10.4103/0253-7613.75664.
3
Pharmacovigilance on olanzapine.奥氮平的药物警戒
Indian J Pharmacol. 2010 Aug;42(4):252-3. doi: 10.4103/0253-7613.68438.
4
Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database.抗精神病药物所致缺血性结肠炎和胃肠道坏死：法国药物警戒数据库综述
Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):948-55. doi: 10.1002/pds.1801.
5
Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.儿科非典型抗精神病药物监测安全性（PAMS）研究：二级和三级医疗机构中儿童及青少年的试点研究
Drug Saf. 2009;32(4):325-33. doi: 10.2165/00002018-200932040-00006.
6
Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?选择性5-羟色胺再摄取抑制剂是青少年自杀的一个风险因素吗？
Can J Psychiatry. 2009 Feb;54(2):69-71; discussion 76-7. doi: 10.1177/070674370905400201.
7
Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder.发表偏倚与制药行业：以拉莫三嗪治疗双相情感障碍为例
Medscape J Med. 2008;10(9):211. Epub 2008 Sep 10.
8
Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.安非他酮戒烟的严重不良反应：对2001年至2004年法国药物警戒数据库的分析
Drug Saf. 2008;31(11):1017-26. doi: 10.2165/00002018-200831110-00006.
9
Industry-sponsored clinical research: a broken system.行业资助的临床研究：一个漏洞百出的体系。
JAMA. 2008 Sep 3;300(9):1069-71. doi: 10.1001/jama.300.9.1069.
10
Pharmacovigilance: methods, recent developments and future perspectives.药物警戒：方法、最新进展与未来展望
Eur J Clin Pharmacol. 2008 Aug;64(8):743-52. doi: 10.1007/s00228-008-0475-9. Epub 2008 Jun 4.
Zotero 插件